The model prediction of KRAS level being higher in the l-OS patient, together with the somatic mutation and with high ERK activation, could lead to the activation of the senescence program of the cancer cells as has been validated in human colon adenocarcinoma cancer models [16]. This evidence concerns the gene KRAS and cancer.